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INTRODUCTION
Thallium-201 chloride (201TlCl) scintigraphy is a
conventional nuclear medicine technique to evaluate
the nature of tumors. Some studies have reported
the utility of 201TlCl scintigraphy in the differentiation
of malignant from benign lesions in various organs,
including soft tissue tumors (1-4). Malignant tumors
typically demonstrate intense uptake, whereas be-
nign lesions show less uptake. However, the differ-
entiation between malignant and benign soft tissue
tumors by the degree of 201TlCl uptake is sometimes
difficult due to the histological variability. 201TlCl
uptake reflects not only a malignant character but
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other factors such as vascularity, cell densities or tis-
sue viability regardless of whether the tumor is be-
nign or malignant.
We report here the findings of 201TlCl scintigraphy
and consider how to use this technique to evaluate
the character of soft tissue lesions.
PATIENTS AND METHODS
We enrolled 91 consecutive patients who were ex-
amined for 201TlCl scintigraphy (45 males and 46 fe-
males, age range 8-91-years-old) in this study. Nine-
teen patients were malignant and 72 were benign.
All 19 patients with malignant lesions were pathologi-
cally proven ; 46 of 72 patients with benign lesions
were pathologically proven, and the other 26 pa-
tients were clinically diagnosed as benign with at
least 6 months of follow up with physical examina-
tions and magnetic resonance imaging. Patients had
111 MBq of 201TlCl, and were scanned 15 minutes
(early phase) and 3 hours (delayed phase) after the
injection. In the early phase, whole body images and
a spot scan of the lesion were obtained and a spot
scan was performed in the delayed phase. For visual
analysis, more intense uptake compared to the nor-
mal side was considered as ‘high’, the same degree
(could not be identified as a tumor) of uptake was
considered ‘iso’, and decreased uptake was ‘low’.
The retention index (RI) was calculated in 9 patients
in the malignant group and in 16 patients in the be-
nign group as follows : RI=(DR-ER)/ER100 (%).
ER (early ratio) is the ratio of lesion count to contra-
lateral soft tissue count in the early phase and DR
(delayed ratio) is the ratio of lesion count to contra-
lateral soft tissue count in the delayed phase.
RESULTS
A summary of the patients is shown in Tables 1
and 2. In malignant tumors, 15 of 19 patients showed
high uptake in both the early and delayed phases
(Figure 1). One malignant fibrous histiocytoma pa-
tient was high only in the delayed phase and 1
liposarcoma patient was high only in the early phase.
Two liposarcoma patients showed an iso uptake in
both phases. One of these patients was pathologically
Table 1 A summary of the patients and the lesions.
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diagnosed as a myxoid type (Figure 2) ; while the
other had fluoro-deoxy-glucose positron emission
computed tomography/computed tomography
(FDG-PET/CT) for follow up of uterine cervical
cancer and was incidentally noticed to have in-
creased nodular uptake in her leg. The tumor
showed iso 201TlCl uptake and was considered
benign at the time, but in the follow up period, a ma-
lignant component was suspected and it was surgi-
cally resected 1.5 years after 201TlCl scintigraphy, and
it was confirmed as liposarcoma pathologically. In
benign lesions, no lipoma showed high uptake (Fig-
ure 3). All neurogenic tumors except for 2 demon-
strated high uptake (Figure 4). All 3 ganglions of the
Table 2 Uptake pattern of 201TlCl scintigraphy. Patients were scanned 15 minutes (early phase) and 3 hours (delayed phase) after
201TlCl injection. More intense uptake in the lesion compared to the normal side was considered as ‘high’, the same degree of uptake




Figure 1 Malignant peripheral nerve sheath tumor (MPNST) in the left femur of patient with neurofiromatosis type I. a : early phase
image of 201TlCl scintigraphy, b : delayed phase image of 201TlCl scintigraphy. MPNST showed high uptake in both early and delayed
phase. c : FIESTA (fast imaging Employing Steady-state Acquisition) image of MRI of coronal view. This tumor demonstrated the
mixed intensity, separated by septum, measured in size of 87.51.5 cm. Another neurogenic tumor is located in the caudal side,
which cannot be detected by 201TlCl scintigraphy. d : Axial T1-weighted SE MR image with fat suppression. Parts of the tumor showed
high intensity, while others showed low intensity compared with the muscle. No fat component was evident in the tumor. e : Axial
gadolinium-enhanced T1-weighted SE MR image with fat suppression showed strongly enhancement.
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Figure 3 Lipoma in the right femur. a : early phase image of 201TlCl scintigraphy, b : delayed phase image of 201TlCl scintigraphy.
The tumor showed iso uptake in both phases of 201TlCl scintigraphy. c : Coronal T2-weighted SE MR image. d : Coronal T1-weighted
SE MR image. e : Coronal T1 weighted SE MR image with fat suppression. f : Coronal gadolinium-enhanced T1-weighted SE MR
image with fat suppression. The tumor was spindle-shaped and showed uniform high intensity on both T1-WI and T2-WI, measur-
ing 1033 cm, and well suppressed on fat -sat T1-WI. Only septum was enhanced and no other solid component was evident.
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Figure 2 Liposarcoma (myxoid type) in the left femur. Iso uptake pattern in both early and delayed phase in malignant lesion. a :
early phase image of 201TlCl scintigraphy. b : delayed phase image. The tumor showed iso uptake in both phases of 201TlCl scintigra-
phy. c : Sagittal T1-weighted SE MR image. d : Sagittal T2-weighted SE MR image. e : Axial T1 weighted SE MR image with fat sup-
pression. f : Sagittal gadolinium-enhanced T1-weighted SE MR image. The tumor, measuring 301745 mm, showed iso intensity
on T1-WI and high intensity on T2-WI compared to the muscle. The tumor intensity was suppressed on fat -suppressed T1-WI and
the tumor showed strong enhancement.
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lower extremities showed iso uptake. Most inflam-
matory diseases showed high uptake. Clinically - con-
sidered benign patients (no pathology) consisted of
tumorous lesions (mainly lipoma and neurogenic
tumor) or inflammatory disease. These tumors are
stable or remitted clinically. Only 2 patients were
considered ‘low’, and these were diagnosed as
intramuscular hematoma and cyst by MRI and CT,
respectively. RI was obtained in only high uptake
patients. RI was variable in both malignant and be-
nign lesions and no statistically significant difference
was seen between malignant and benign lesions by
t-test (p=0.72) (Figure 5).
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Figure 4 Schwannoma in the left forearm. a : early phase image of 201TlCl scintigraphy, b : delayed phase image of 201TlCl scintigraphy.
Tumor showed high uptake in both early and delayed phase of 201TlCl scintigraphy. c : Coronal T2-weighted SE MR image. The tu-
mor was oval -shaped, measuring 383555 mm, and showed peripheral high intensity and central low intensity. d : Coronal T1-
weighted SE MR image. The tumor showed peripheral iso- intensity and central slight high intensity compared with the muscle. e :
Coronal gadolinium-enhanced T1-weighted SE MR image with fat suppression. The tumor showed central significant enhancement.
Figure 5 Retention Index (RI) was cal-
culated in 25 patients (9 malignant and 16
benign lesions). there were significant
overlap between malignant and benign le-
sion, and no statistical difference was ob-
served (p=0.72).
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DISCUSSION
It is important to evaluate the nature of a lesion
and differentiate malignant from benign in the man-
agement of patients with soft tissue tumors. Imaging
techniques are essential and 201TlCl scintigraphy has
played an important role. FDG-PET is newly devel-
oped in tumor imaging but the clinical indication for
soft tissue tumor is limited and not so widely used
compared with 201TlCl scintigraphy (5). Thallium is
a potassium analogue and accumulates in tumors re-
flecting many factors. There are some reports that
have described the utility of 201TlCl scintigraphy in
the differentiation of malignant from benign lesions
based on the degree of 201TlCl uptake. In dual time
scanning (early and delayed phase), the early phase
uptake mainly reflects tumor vascularity and the
delayed phase uptake substantially reflects tumor vi-
ability. In our study, most of the malignant lesions
demonstrated high uptake in both the early and
delayed phases. Two of the malignant tumors that
showed iso uptake were liposarcoma. In these cases,
Gadolinium-enhanced MRI was useful to detect ill-
defined malignant soft tissue components. It is re-
ported that a low 201TlCl uptake is shown in well-
differentiated or myxoid liposarcoma (6). One of our
patients was incidentally detected by FDG-PET/CT
for follow up of uterine cervical cancer, and the le-
sion showed high FDG uptake. The tumor was re-
sected 1.5 years after 201TlCl scintigraphy and was
proven as liposarcoma. We were unable to deter-
mine the existence of a malignant component at the
time of 201TlCl scintigraphy. The RI is reportedly use-
ful for differentiating benign from malignant tumors.
In our study, we calculated RI in high uptake pa-
tients. The RI was variable in both malignant and be-
nign lesions, and no statistically significant difference
was observed. We believe that this is due to histo-
logical variability, variable lesion size and normal
physiological muscle uptake. We evaluated RI using
planar images that demonstrated an overlapped up-
take in the lesion and normal muscle. A small lesion
is sometimes masked by surrounding tissue and
may not show high uptake.
A high 201TlCl uptake is more frequently seen in
malignant tumors, but regardless of whether the tu-
mor is benign or malignant, according to the histo-
pathological variety, the 201TlCl uptake pattern can
not be the only indicator to differentiate malignant
from benign tumors. We ultimately need to evaluate
the nature of tumors by a combination of several im-
aging techniques.
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